Sally Beauty Holdings (SBH) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 May, 2026Executive summary
Second quarter fiscal 2026 net sales reached $903.4 million, up 2.3% year-over-year, with comparable sales growth of 1.3% and a $12.8 million positive FX impact.
Adjusted operating income was $73 million and adjusted diluted EPS was $0.44, both above guidance; GAAP diluted EPS increased 13% to $0.43.
Cash flow from operations was $73.3 million, enabling $20 million in debt paydown and $25 million in share repurchases.
Sally segment showed resilience, with U.S. and Canada comparable sales up 4.4% and strong performance in color and nail categories.
BSG segment delivered improved profitability with operating margin up 90 basis points to 12.4% on flat sales.
Financial highlights
Consolidated net sales grew 2.3% year-over-year to $903.4 million, including 150 basis points of favorable FX impact.
Global e-commerce sales rose 13% to $108 million, representing 12% of total net sales.
Adjusted gross margin expanded 80 basis points to 52.8%, driven by higher product margin and Fuel for Growth program benefits.
Adjusted SG&A was $404 million, up $14 million year-over-year, mainly due to labor, rent, and FX.
Free cash flow was $44 million; cash equivalents at quarter end were $157 million.
Outlook and guidance
Full-year consolidated net sales expected between $3.725 billion and $3.750 billion, with comparable sales flat to up 1%.
Adjusted operating earnings forecasted at $328 million-$342 million; adjusted diluted EPS at $2.02-$2.10.
Q3 net sales guidance: $932 million-$942 million; adjusted EPS $0.52-$0.56.
FY26 free cash flow expected at ~$200 million; capital expenditures projected at $100 million.
Management expects existing cash, operations, and available credit to be sufficient for working capital and capital expenditures over the next twelve months.
Latest events from Sally Beauty Holdings
- Adjusted EPS up 12% as net sales rose 0.6% and FY26 guidance was raised.SBH
Q1 20269 Apr 2026 - Q4 and FY24 saw sales and margin growth, fueling a positive 2025 outlook and capital returns.SBH
Q4 20243 Feb 2026 - Q3 sales up 1.2%, but net earnings fell 25.8% amid margin and interest pressures.SBH
Q3 20242 Feb 2026 - Operating margin and EPS rose despite a 2.8% sales decline and macro headwinds.SBH
Q2 202523 Jan 2026 - Operating margin and EPS rose as guidance was raised, despite lower sales and macro uncertainty.SBH
Q3 202523 Jan 2026 - Net sales and margins grew, net earnings surged, and guidance remains positive despite FX headwinds.SBH
Q1 202523 Jan 2026 - FY2025 saw strong sales, margin gains, and cash flow, supporting double-digit EPS growth outlook.SBH
Q4 202523 Jan 2026 - Virtual annual meeting to vote on directors, compensation, and auditor, with online access promoted.SBH
Proxy Filing10 Dec 2025 - Strong FY25 results, digital expansion, and robust ESG focus drive governance and compensation.SBH
Proxy Filing10 Dec 2025